Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,190 total articles
Broadcom's mix of semiconductors and infrastructure software positions it squarely in the fastest-growing parts of the tech stack. With a $1.74 trillion market cap, double-digit profitability metrics, and multiple industry-level catalysts coming into focus, this trade idea favors a measured long ahead of further AI-related revenue realization. The …
Magellan Aerospace (MALJF) is trading at $23.81 with a market cap of $1.36B and a tiny public float. A Chapter 11 filing has pushed headline risk to the fore, but the company’s revenue mix, defense exposure, and a restructuring timeline create the potential for a material rebound. This trade idea lays out an actionable entry, stop, and target with …
ZIM trades below a reported $35 buyout price but also offers a 6.5% yield and improving operational momentum. This trade picks a controlled long with defined risk, aiming to capture deal upside or an income-supported re-rating if the acquisition stalls.
Fastly has moved from a turnaround story into a growth reacceleration play. Revenue and gross margins are improving, technicals are constructive, and the stock is trading at a market cap of about $4.16B. This trade targets a move back to the 52-week range by buying a disciplined entry with a $22 stop.
Eutelsat offers a practical way to play consolidation of European satellite infrastructure. The company combines legacy GEO capacity with an expanding LEO angle, visible defense/government demand, and predictable cash flows from video and connectivity customers. This trade targets a rebound as integration wins and satellite launches validate synerg…
YETI is trading near $43.58 after an investor day that laid out clear growth targets and a framework for margin expansion. Direct-to-consumer sales and international expansion are the operational levers; valuation is reasonable given an EV of ~$3.16B and an implied P/E near 18. The trade: buy into DTC momentum with a mid-term horizon to capture mar…
Pfizer offers a compelling income entry at current levels with a 6.2% yield, $11B in free cash flow, and a market cap near $159B. Balance sheet metrics are workable, and the stock trades between its 50-day and 20-day moving averages. This trade idea sets a clear entry at $27.93, a stop at $25.50 and a primary target at $32.00 tied to near-term pipe…
Enterprise Products Partners (EPD) offers a mix of high yield (≈5.7%), substantial free cash flow ($3.46B), and a conservative valuation (P/E ~13.2, EV/EBITDA ~11.4). This trade idea advocates a long position at $38.10 with a $44 target and $35 stop, sized for a mid/long-term horizon where income and fee-based contracts provide downside support whi…
Frontline has been riding an outsized tanker-rate cycle driven by Strait of Hormuz disruptions and asset sales that have boosted near-term cash returns. With a market cap of $10.7B, a trailing PE of 7.5 and a 6.3% yield, the stock already prices in a lot of near-term cash. I see a credible path to lower earnings in 2027 as spot rates normalize and …
ODFJELL DRILLING (ODFJF) is showing strong technical momentum and abnormal short-interest dynamics that create an asymmetric return profile for buyers. With price above all major moving averages, bullish MACD, and multiple days of elevated short volume, we prefer a tactical long for a mid-term horizon while keeping a tight stop to limit downside if…
Vicor's announcement on 09/16/2026 that it licensed its Vertical Power Delivery (VPD) modules to a leading AI OEM is a structural inflection. The move converts proprietary module sales into recurring royalty streams, reduces single-source risk for hyperscalers, and accelerates revenue leverage as Vicor scales fabs. Valuation is rich at a $12.38B ma…
Labcorp (LH) faces a near-term reimbursement headwind after CMS announced cuts, yet the company’s exposure to clinical trials, molecular diagnostics and growing biopharma testing gives it an asymmetric recovery profile. At a market cap near $25.3B and a P/E of ~26.5, LH looks reasonably valued for a patient long-term trade entry after the recent pu…
GE Aerospace has the scale, aftermarket cash flow and a $210 billion backlog to absorb near-term airline pain from $100 oil. Technicals show near-term consolidation, offering a tactical entry for a mid-term (45 trading days) long. This trade targets operational resiliency plus upside from the recent CPP acquisition, while maintaining a clear stop f…
Nano Labs (NA) trades at ~$2.41 with a market cap of roughly $55M after a tough H1 that included a large crypto-related mark-to-market loss. The company has real IP in AI/vision chips, a new consumer/edge product (iPollo ClawPC A1 Mini), a 70,000 BNB strategic reserve and a North America MOU to build AI infrastructure. Those pieces create a credibl…
dLocal remains a rare high-growth payments franchise focused on emerging markets. Recent headlines around declining take rates have rattled the stock, but underlying momentum - $14bn TPV, 153% net revenue retention and accelerating gross profit - supports a constructive mid-term trade. I lay out an entry at $14.28, a stop at $11.75 and a target of …
Palantir is expensive on headline multiples, but its combination of positive free cash flow ($3.36B), no debt, double-digit profitability and accelerating analyst revisions suggests the market is underestimating the ease of a $10 billion re-rating. This is a tactical swing trade: enter on strength, respect a structured stop, and take profits as mom…
Ponce Financial Group (PDLB) trades near $20.80 with a market cap just under $500M and free cash flow north of $57M. The company still carries $225M of senior perpetual preferred stock that has had its dividend rate temporarily reduced under ECIP. If management chooses to retire a meaningful portion of that preferred, earnings power and return metr…
Meta’s Muse AI breakthrough has moved the needle from promise to monetization. With a $1.89T market cap, healthy free cash flow, and clear ad/engagement leverage from AI agents, the stock looks actionable for a long trade over the next 180 trading days. Entry $745.00, target $900.00, stop $700.00.
Arhaus (ARHS) combines consistent free cash flow, a low net-debt profile and tangible growth catalysts (catalog scale-up, showroom openings, luxury upholstery expansion). The stock trades at a reasonable ~17.9x forward earnings and an EV/EBITDA of ~6.6x, leaving upside to the $12 area while offering a defined risk if traffic and margin trends deter…
Candel Therapeutics (CADL) is a high-conviction long idea ahead of an anticipated biologics license application (BLA) filing for aglatimagene in localized prostate cancer in Q4. Positive phase 3 signals, a recent $100M capital raise to fund launch readiness, and a market cap below $1B create an asymmetric risk/reward if the FDA accepts the filing a…
Itron's product cadence (IEE Cloud AI), operational leverage and resilient free cash flow create a compelling long-term trade. The company is attractively valued relative to its cash generation and growth opportunities in smart metering and grid-edge analytics. Buy with a clear entry at $92.92, target $110.00 and stop $81.00 for a long-term (180 tr…
Texas Instruments has the revenue momentum, cash generation and dividend profile that make it a compelling tactical long. With data-center revenue doubling, 23% top-line growth and a strong free-cash-flow base, TXN is well positioned to benefit from rising chip content in industrial, automotive and AI infrastructure. This trade plan targets upside …
Intel is trading at $121.81 with clear technical momentum, improving product cadence (Core Ultra expansion), and active institutional participation. The company still carries negative EPS and a rich valuation by some metrics, but positive free cash flow, meaningful market cap ($640.3B) and growing AI/CPU demand create a tradeable asymmetric setup. …
<p>Nano One looks like a classic 'technology meets defense' arbitrage: a niche cathode/battery-materials company with scale-up milestones that could make it an attractive supplier to drone integrators and defense primes. The opportunity is binary but tangible - military buyers want higher energy density, better thermal stability and ruggedized supp…
SK hynix stands to be an outsized beneficiary of the AI memory cycle: expanding HBM content per accelerator and improving pricing should drive earnings leverage. The optionality of a deeper Intel relationship - whether a multi-year HBM supply contract, co-developed HBM for Intel accelerators, or a strategic supply agreement - could materially accel…
